Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/500μg vs Fluticasone Propionate 500μg in Patients with Corticosteroid-Dependent Asthma V: Results

被引：0
|
作者：
Willem R. Pieters
Bo Lundbäck
Seema Sondhi
Martin J. Price
Robert M.A. Thwaites
机构：
[1] Elkerliek Ziekenhuis,Respiratory Unit
[2] National Institute for Working Life,Global Health Outcomes
[3] Glaxo Wellcome,undefined
来源：
PharmacoEconomics | 1999年 / 16卷
关键词：
Asthma; Adis International Limited; Fluticasone Propionate; Salmeterol; Formoterol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Methods: An economic analysis was performed to compare the cost effectiveness of a new formulation combining salmeterol 50μg and fluticasone propionate 500μg in a multidose dry powder (Diskus™) inhaler (n = 167) with that of fluticasone propionate (FP) 500μg (n = 165) also delivered via the Diskus™ in patients with corticosteroid-dependent asthma. Clinical data were obtained from a recent European multicentre trial; the economic analysis adopted a Swedish healthcare perspective.
引用
收藏
页码：29 / 34
页数：5
相关论文
共 49 条
12345